Hawaii Biotech hibiotech.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. Lead vaccine candidates in clinical development target the West Nile virus and Dengue virus. Additional recombinant protein subunits vaccine candidates produced from this protein production platf...Show all

Hawaii Biotech (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. The company has developed expertise in the production of recombinant proteins applica...Show all

Company (Alive / Active)

Phone: 808-486-5333

Fax:

650 Iwilei Road, Suite 204
Suite 200
Honolulu, 96817
Hawaii, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Hawaii Biotech $55.9M Oct 31, 2018
See all 31 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Hawaii Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Board Members

Competitors

Company Status Description Investors
See all 31 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hydroxamic acids and uses thereof Sep 29, 2016 Jun 27, 2017 Patent
Recombinant subunit west nile virus vaccine for protection of human subjects Oct 21, 2016 Application